keyword
MENU ▼
Read by QxMD icon Read
search

CRTAP

keyword
https://www.readbyqxmd.com/read/27864101/targeted-exome-sequencing-identifies-novel-compound-heterozygous-mutations-in-p3h1-in-a-fetus-with-osteogenesis-imperfecta-type-viii
#1
Yanru Huang, Libin Mei, Weigang Lv, Haoxian Li, Rui Zhang, Qian Pan, Hu Tan, Jing Guo, Xiaomei Luo, Chen Chen, Desheng Liang, Lingqian Wu
Osteogenesis imperfecta (OI) is a highly clinically and genetically heterogeneous group of disorders. It is difficult to identify severe OI in the perinatal period. Here, a Chinese woman with a suspected history of fetal OI was referred to our institution at 19weeks of gestation, due to ultrasound inspection during antenatal screening, which revealed bulbous metaphyses, short humeri, and short thick bent femora in the fetus. Using targeted exome sequencing of 248 genes known to be involved in skeletal system diseases, we identified novel compound heterozygous mutation in the P3H1 gene in the fetus with OI type VIII: c...
November 15, 2016: Clinica Chimica Acta; International Journal of Clinical Chemistry
https://www.readbyqxmd.com/read/27651116/transcriptome-meta-analysis-reveals-a-dysregulation-in-extra-cellular-matrix-and-cell-junction-associated-gene-signatures-during-dengue-virus-infection
#2
Sumbul Afroz, Jeevan Giddaluru, Mohd Manzar Abbas, Nooruddin Khan
Dengue Viruses (DENVs) cause one of the most prevalent arthropod-borne viral diseases affecting millions of people worldwide. Identification of genes involved in DENV pathogenesis would help in deciphering molecular mechanisms responsible for the disease progression. Here, we carried out a meta-analysis of publicly available gene expression data of dengue patients and further validated the meta-profile using in-vitro infection in THP-1 cells. Our findings reveal that DENV infection modulates expression of several genes and signalling pathways including interferons, detoxification of ROS and viral assembly...
2016: Scientific Reports
https://www.readbyqxmd.com/read/27649409/correlations-between-bone-mechanical-properties-and-bone-composition-parameters-in-mouse-models-of-dominant-and-recessive-osteogenesis-imperfecta-and-the-response-to-anti-tgf-%C3%AE-treatment
#3
Xiaohong Bi, Ingo Grafe, Hao Ding, Rene Flores, Elda Munivez, Ming Ming Jiang, Brian Dawson, Brendan Lee, Catherine G Ambrose
Osteogenesis Imperfecta (OI) is a group of genetic disorders characterized by brittle bones that are prone to fracture. While previous studies in animal models investigated the mechanical properties and material composition of OI bone, little work has been conducted to statistically correlate these parameters to identify key compositional contributors to the impaired bone mechanical behaviors in OI. Further, while increased TGF-β signaling has been demonstrated as a contributing mechanism to the bone pathology in OI models, the relationship between mechanical properties and bone composition after anti-TGF-β treatment in OI has not been studied...
September 20, 2016: Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research
https://www.readbyqxmd.com/read/27509835/dna-sequence-analysis-in-598-individuals-with-a-clinical-diagnosis-of-osteogenesis-imperfecta-diagnostic-yield-and-mutation-spectrum
#4
G Bardai, P Moffatt, F H Glorieux, F Rauch
: We detected disease-causing mutations in 585 of 598 individuals (98 %) with typical features of osteogenesis imperfecta (OI). In mild OI, only collagen type I encoding genes were involved. In moderate to severe OI, mutations in 12 different genes were found; 11 % of these patients had mutations in recessive genes. INTRODUCTION: OI is usually caused by mutations in COL1A1 or COL1A2, the genes encoding collagen type I alpha chains, but mutations in at least 16 other genes have also been associated with OI...
August 11, 2016: Osteoporosis International
https://www.readbyqxmd.com/read/27362741/novel-fkbp10-mutation-in-a-patient-with-osteogenesis-imperfecta-type-xi
#5
Seyed Mohammad Seyedhassani, Feyzollah Hashemi-Gorji, Mahdieh Yavari, Fahimeh Harazi, Vahid Reza Yassaee
Osteogenesis imperfecta (OI) is a set of clinically and genetically heterogeneous disorders with autosomal dominant, recessive and X-linked inheritance patterns. The aim of this study was to describe a novel genetic abnormality in a case of OI type XI with mild joint contractures, kyphoscoliosis, muscular atrophy, progressively deforming and multiple bone fractures in a consanguineous Iranian family. Based on the phenotype, investigation of two candidate genes, CRTAP (OI type VII) and FKBP10 (OI type XI) detected a novel homozygous frameshift mutation in the FKBP10 gene...
June 30, 2016: Fetal and Pediatric Pathology
https://www.readbyqxmd.com/read/27335225/next-generation-sequencing-of-common-osteogenesis-imperfecta-related-genes-in-clinical-practice
#6
Kristóf Árvai, Péter Horváth, Bernadett Balla, Bálint Tobiás, Karina Kató, Gyöngyi Kirschner, Valéria Klujber, Péter Lakatos, János P Kósa
Next generation sequencing (NGS) is a rapidly developing area in genetics. Utilizing this technology in the management of disorders with complex genetic background and not recurrent mutation hot spots can be extremely useful. In this study, we applied NGS, namely semiconductor sequencing to determine the most significant osteogenesis imperfecta-related genetic variants in the clinical practice. We selected genes coding collagen type I alpha-1 and-2 (COL1A1, COL1A2) which are responsible for more than 90% of all cases...
2016: Scientific Reports
https://www.readbyqxmd.com/read/26716893/sclerostin-antibody-treatment-improves-the-bone-phenotype-of-crtap-mice-a-model-of-recessive-osteogenesis-imperfecta
#7
Ingo Grafe, Stefanie Alexander, Tao Yang, Caressa Lietman, Erica P Homan, Elda Munivez, Yuqing Chen, Ming Ming Jiang, Terry Bertin, Brian Dawson, Franklin Asuncion, Hua Zhu Ke, Michael S Ominsky, Brendan Lee
Osteogenesis imperfecta (OI) is characterized by low bone mass, poor bone quality, and fractures. Standard treatment for OI patients is limited to bisphosphonates, which only incompletely correct the bone phenotype, and seem to be less effective in adults. Sclerostin-neutralizing antibodies (Scl-Ab) have been shown to be beneficial in animal models of osteoporosis, and dominant OI resulting from mutations in the genes encoding type I collagen. However, Scl-Ab treatment has not been studied in models of recessive OI...
May 2016: Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research
https://www.readbyqxmd.com/read/26634552/mutational-characterization-of-the-p3h1-crtap-cypb-complex-in-recessive-osteogenesis-imperfecta
#8
C Barbirato, M Trancozo, M G Almeida, L S Almeida, T O Santos, J C G Duarte, M R G O Rebouças, V Sipolatti, V R R Nunes, F Paula
Osteogenesis imperfecta (OI) is a genetic disease characterized by bone deformities and fractures. Most cases are caused by autosomal dominant mutations in the type I collagen genes COL1A1 and COL1A2; however, an increasing number of recessive mutations in other genes have been reported. The LEPRE1, CRTAP, and PPIB genes encode proteins that form the P3H1/CRTAP/CypB complex, which is responsible for posttranslational modifications of type I collagen. In general, mutations in these genes lead to severe and lethal phenotypes of recessive OI...
2015: Genetics and Molecular Research: GMR
https://www.readbyqxmd.com/read/25798844/mir-200-promotes-the-mesenchymal-to-epithelial-transition-by-suppressing-multiple-members-of-the-zeb2-and-snail1-transcriptional-repressor-complexes
#9
R Perdigão-Henriques, F Petrocca, G Altschuler, M P Thomas, M T N Le, S M Tan, W Hide, J Lieberman
The miR-200 family promotes the epithelial state by suppressing the Zeb1/Zeb2 epithelial gene transcriptional repressors. To identify other miR-200-regulated genes, we isolated mRNAs bound to transfected biotinylated miR-200c in mouse breast cancer cells. In all, 520 mRNAs were significantly enriched in miR-200c binding at least twofold. Putative miR-200-regulated genes included Zeb2, enriched 3.5-fold in the pull down. However, Zeb2 knockdown does not fully recapitulate miR-200c overexpression, suggesting that regulating other miR-200 targets contributes to miR-200's enhancement of epithelial gene expression...
January 14, 2016: Oncogene
https://www.readbyqxmd.com/read/25742658/development-of-a-high-throughput-resequencing-array-for-the-detection-of-pathogenic-mutations-in-osteogenesis-imperfecta
#10
Yao Wang, Yazhou Cui, Xiaoyan Zhou, Jinxiang Han
OBJECTIVE: Osteogenesis imperfecta (OI) is a rare inherited skeletal disease, characterized by bone fragility and low bone density. The mutations in this disorder have been widely reported to be on various exonal hotspots of the candidate genes, including COL1A1, COL1A2, CRTAP, LEPRE1, and FKBP10, thus creating a great demand for precise genetic tests. However, large genome sizes make the process daunting and the analyses, inefficient and expensive. Therefore, we aimed at developing a fast, accurate, efficient, and cheaper sequencing platform for OI diagnosis; and to this end, use of an advanced array-based technique was proposed...
2015: PloS One
https://www.readbyqxmd.com/read/25604815/crtap-mutation-in-a-patient-with-cole-carpenter-syndrome
#11
Meena Balasubramanian, Rebecca C Pollitt, Kate E Chandler, M Z Mughal, Michael J Parker, Ann Dalton, Paul Arundel, Amaka C Offiah, Nicholas J Bishop
In 1987, Cole and Carpenter reported two unrelated infants with multiple fractures and deformities of bone, with a skeletal phenotype similar to severe osteogenesis imperfecta. In addition, these patients also had proptosis, blue sclerae, hydrocephalus, and a distinct facial gestalt. They were reported to be of normal intelligence. Radiologically, these patients had characteristic skeletal manifestations including craniosynostosis and deformities similar to severe progressive osteogenesis imperfecta. Since the first description, there have only been a few other reports of patients with a similar phenotype...
March 2015: American Journal of Medical Genetics. Part A
https://www.readbyqxmd.com/read/25565926/novel-deletion-of-serpinf1-causes-autosomal-recessive-osteogenesis-imperfecta-type-vi-in-two-brazilian-families
#12
Renata Moldenhauer Minillo, Nara Sobreira, Maria de Fatima de Faria Soares, Julie Jurgens, Hua Ling, Kurt N Hetrick, Kimberly F Doheny, David Valle, Decio Brunoni, Ana B Alvarez Perez
Autosomal recessive osteogenesis imperfecta (OI) accounts for 10% of all OI cases, and, currently, mutations in 10 genes (CRTAP, LEPRE1, PPIB, SERPINH1, FKBP10, SERPINF1, SP7, BMP1, TMEM38B, and WNT1) are known to be responsible for this form of the disease. PEDF is a secreted glycoprotein of the serpin superfamily that maintains bone homeostasis and regulates osteoid mineralization, and it is encoded by SERPINF1, currently associated with OI type VI (MIM 172860). Here, we report a consanguineous Brazilian family in which multiple individuals from at least 4 generations are affected with a severe form of OI, and we also report an unrelated individual from the same small city in Brazil with a similar but more severe phenotype...
December 2014: Molecular Syndromology
https://www.readbyqxmd.com/read/25450603/mutations-in-patients-with-osteogenesis-imperfecta-from-consanguineous-indian-families
#13
Joshi Stephen, Katta Mohan Girisha, Ashwin Dalal, Anju Shukla, Hitesh Shah, Priyanka Srivastava, Uwe Kornak, Shubha R Phadke
Osteogenesis imperfecta (OI) is a spectrum of genetic disorders with decreased bone density and bone fragility. Most of the cases of OI are inherited in autosomal dominant fashion with mutations in COL1A1 or COL1A2 genes. Over last few years, twelve genes for autosomal recessive OI have been identified. In this study we have evaluated seven patients with OI from consanguineous Indian families. Homozygosity mapping using SNP microarray was done and selected candidate genes were sequenced. Candidate genes were identified in four out of seven patients studied...
January 2015: European Journal of Medical Genetics
https://www.readbyqxmd.com/read/25046257/what-is-new-in-genetics-and-osteogenesis-imperfecta-classification
#14
REVIEW
Eugênia R Valadares, Túlio B Carneiro, Paula M Santos, Ana Cristina Oliveira, Bernhard Zabel
OBJECTIVE: Literature review of new genes related to osteogenesis imperfecta (OI) and update of its classification. SOURCES: Literature review in the PubMed and OMIM databases, followed by selection of relevant references. SUMMARY OF THE FINDINGS: In 1979, Sillence et al. developed a classification of OI subtypes based on clinical features and disease severity: OI type I, mild, common, with blue sclera; OI type II, perinatal lethal form; OI type III, severe and progressively deforming, with normal sclera; and OI type IV, moderate severity with normal sclera...
November 2014: Jornal de Pediatria
https://www.readbyqxmd.com/read/25007323/osteogenesis-imperfecta-due-to-mutations-in-non-collagenous-genes-lessons-in-the-biology-of-bone-formation
#15
REVIEW
Joan C Marini, Adi Reich, Simone M Smith
PURPOSE OF REVIEW: Osteogenesis imperfecta or 'brittle bone disease' has mainly been considered a bone disorder caused by collagen mutations. Within the last decade, however, a surge of genetic discoveries has created a new paradigm for osteogenesis imperfecta as a collagen-related disorder, where most cases are due to autosomal dominant type I collagen defects, while rare, mostly recessive, forms are due to defects in genes whose protein products interact with collagen protein. This review is both timely and relevant in outlining the genesis, development, and future of this paradigm shift in the understanding of osteogenesis imperfecta...
August 2014: Current Opinion in Pediatrics
https://www.readbyqxmd.com/read/24835313/a-novel-deletion-mutation-involving-tmem38b-in-a-patient-with-autosomal-recessive-osteogenesis-imperfecta
#16
Elisa Rubinato, Anna Morgan, Angela D'Eustacchio, Vanna Pecile, Giulia Gortani, Paolo Gasparini, Flavio Faletra
Osteogenesis imperfecta (OI) is a hereditary bone disease characterized by decreased bone density and multiple fractures, usually inherited in an autosomal dominant manner. Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including CRTAP, LEPRE1, PPIB, FKBP65, SERPINF1, BMP1, WNT1, FKBP10). Recently, TMEM38B, a gene that encodes TRIC-B, a monovalent cation-specific channel involved in calcium flux from intracellular stores and in cell differentiation, has been associated with autosomal recessive OI...
July 25, 2014: Gene
https://www.readbyqxmd.com/read/24793237/excessive-transforming-growth-factor-%C3%AE-signaling-is-a-common-mechanism-in-osteogenesis-imperfecta
#17
Ingo Grafe, Tao Yang, Stefanie Alexander, Erica P Homan, Caressa Lietman, Ming Ming Jiang, Terry Bertin, Elda Munivez, Yuqing Chen, Brian Dawson, Yoshihiro Ishikawa, Mary Ann Weis, T Kuber Sampath, Catherine Ambrose, David Eyre, Hans Peter Bächinger, Brendan Lee
Osteogenesis imperfecta (OI) is a heritable disorder, in both a dominant and recessive manner, of connective tissue characterized by brittle bones, fractures and extraskeletal manifestations. How structural mutations of type I collagen (dominant OI) or of its post-translational modification machinery (recessive OI) can cause abnormal quality and quantity of bone is poorly understood. Notably, the clinical overlap between dominant and recessive forms of OI suggests common molecular pathomechanisms. Here, we show that excessive transforming growth factor-β (TGF-β) signaling is a mechanism of OI in both recessive (Crtap(-/-)) and dominant (Col1a2(tm1...
June 2014: Nature Medicine
https://www.readbyqxmd.com/read/24465224/differential-effects-of-collagen-prolyl-3-hydroxylation-on-skeletal-tissues
#18
Erica P Homan, Caressa Lietman, Ingo Grafe, Jennifer Lennington, Roy Morello, Dobrawa Napierala, Ming-Ming Jiang, Elda M Munivez, Brian Dawson, Terry K Bertin, Yuqing Chen, Rhonald Lua, Olivier Lichtarge, John Hicks, Mary Ann Weis, David Eyre, Brendan H L Lee
Mutations in the genes encoding cartilage associated protein (CRTAP) and prolyl 3-hydroxylase 1 (P3H1 encoded by LEPRE1) were the first identified causes of recessive Osteogenesis Imperfecta (OI). These proteins, together with cyclophilin B (encoded by PPIB), form a complex that 3-hydroxylates a single proline residue on the α1(I) chain (Pro986) and has cis/trans isomerase (PPIase) activity essential for proper collagen folding. Recent data suggest that prolyl 3-hydroxylation of Pro986 is not required for the structural stability of collagen; however, the absence of this post-translational modification may disrupt protein-protein interactions integral for proper collagen folding and lead to collagen over-modification...
January 2014: PLoS Genetics
https://www.readbyqxmd.com/read/23959653/sc65-is-a-novel-endoplasmic-reticulum-protein-that-regulates-bone-mass-homeostasis
#19
Katrin Gruenwald, Patrizio Castagnola, Roberta Besio, Milena Dimori, Yuqing Chen, Nisreen S Akel, Frances L Swain, Robert A Skinner, David R Eyre, Dana Gaddy, Larry J Suva, Roy Morello
Members of the Leprecan family of proteins include enzymes, prolyl 3-hydroxylase 1 (P3h1), P3h2, and P3h3, and nonenzymatic proteins, Crtap and Sc65. Mutations in CRTAP and LEPRE1 (encoding P3H1) have been associated with human disease such as recessive osteogenesis imperfecta; however, the function of Sc65, which is closely related and highly homologous to Crtap, is unknown. Sc65 has been described as a synaptonemal complex protein, a nucleolar protein, and a cytoplasmic adapter protein. In light of its high sequence similarity with Crtap, an endoplasmic reticulum (ER)-associated protein, and the importance of post-translational modifications such as collagen prolyl 3-hydroxylation in bone metabolism, we hypothesized that Sc65 was an ER-resident protein that would have an important role in bone homeostasis...
March 2014: Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research
https://www.readbyqxmd.com/read/23772978/collagen-prolyl-3-hydroxylation-a-major-role-for-a-minor-post-translational-modification
#20
REVIEW
David M Hudson, David R Eyre
Prolyl 3-hydroxylation is a rare but conserved post-translational modification in many collagen types and, when defective, may be linked to a number of human diseases with musculoskeletal and potentially ocular and renal pathologies. Prolyl 3-hydroxylase-1 (P3H1), the enzyme responsible for converting proline to 3-hydroxyproline (3Hyp) in type I collagen, requires the coenzyme CRTAP for activity. Mass spectrometric analysis showed that the Crtap-/- mouse was missing 3-hydroxyproline in type I collagen α-chains...
2013: Connective Tissue Research
keyword
keyword
36138
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"